Company Registration No. SC487069 (Scotland)
G S Biotech Ltd
Unaudited accounts
for the year ended 30 September 2019
G S Biotech Ltd
Unaudited accounts
Contents
G S Biotech Ltd
Company Information
for the year ended 30 September 2019
Director
Mr Charles Pollock
Company Number
SC487069 (Scotland)
Registered Office
34 Newmarket Street
Ayr
Ayrshire
KA7 1LP
Scotland
Accountants
McKinnon & Co Ltd ACPA
34 Newmarket Street
Ayr
Ayrshire
KA7 1LP
G S Biotech Ltd
Statement of financial position
as at
30 September 2019
Tangible assets
13,665
15,151
Inventories
78,322
33,514
Cash at bank and in hand
-
11,669
Creditors: amounts falling due within one year
(111,473)
(50,829)
Net current assets
13,240
10,808
Total assets less current liabilities
26,905
25,959
Creditors: amounts falling due after more than one year
(118,321)
(121,250)
Net liabilities
(91,416)
(95,291)
Called up share capital
100
100
Profit and loss account
(91,516)
(95,391)
Shareholders' funds
(91,416)
(95,291)
For the year ending 30 September 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the Board on 17 May 2020.
Mr Charles Pollock
Director
Company Registration No. SC487069
G S Biotech Ltd
Notes to the Accounts
for the year ended 30 September 2019
G S Biotech Ltd is a private company, limited by shares, registered in Scotland, registration number SC487069. The registered office is 34 Newmarket Street, Ayr, Ayrshire, KA7 1LP, Scotland.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
Depreciation charged at 20%
4
Tangible fixed assets
Plant & machinery
Cost or valuation
At cost
At 30 September 2019
30,937
Charge for the year
3,416
At 30 September 2019
17,272
At 30 September 2019
13,665
At 30 September 2018
15,151
Raw materials
57,680
16,014
Work in progress
20,642
17,500
G S Biotech Ltd
Notes to the Accounts
for the year ended 30 September 2019
Trade debtors
46,391
16,454
7
Creditors: amounts falling due within one year
2019
2018
Bank loans and overdrafts
11,071
-
Trade creditors
25,731
10,182
Taxes and social security
(1,310)
(4,873)
Loans from directors
73,481
44,440
8
Creditors: amounts falling due after more than one year
2019
2018
Other creditors
71,250
71,250
9
Average number of employees
During the year the average number of employees was 0 (2018: 3).